Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Medical Oncology 3

2 abstracts

Abstract
Ramucirumab plus paclitaxel as switch maintenance versus continuation of oxaliplatin-based chemotherapy in patients (pts) with advanced HER2-negative gastric or gastroesophageal junction (GEJ) cancer: The ARMANI phase III trial.
Org: Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Veneto Institute of Oncology IOV–IRCCS, Azienda Ospedaliero Universitaria Santa Maria della Misericordia, Ospedale Santa Maria delle Croci,
Abstract
Understanding resistance in V600E BRAF advanced colon cancer treated with BRAF inhibitors plus anti-EGFR antibodies +/- MEK inhibitors: The URBAN study.
Org: Medical Oncology 1, Venetian Institute of Oncology-IRCCS, Padua, Padua, Italy, Department of Oncology and Haematology, Division of Oncology, University Hospital of Modena, Modena, Italy, Veneto Institute of Oncology IOV–IRCCS, Padua, Italy, Department of Medicine (DIMED) University of Padua and Veneto Institute of Oncology (IOV-IRCCS ),